Caplin Point Laboratories Limited (BOM:524742)
India
· Delayed Price · Currency is INR 2,015.80
+11.25 (0.56%)
At close: May 14, 2025
Caplin Point Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 19,375 | 16,941 | 14,667 | 12,694 | 10,613 | Upgrade
|
| Other Revenue | 964.3 | 20.1 | 15.9 | 15.4 | 10.6 | Upgrade
|
| Revenue | 20,339 | 16,961 | 14,683 | 12,710 | 10,624 | Upgrade
|
| Revenue Growth (YoY) | 19.92% | 15.51% | 15.53% | 19.64% | 22.96% | Upgrade
|
| Cost of Revenue | 7,708 | 7,561 | 6,792 | 5,724 | 4,806 | Upgrade
|
| Gross Profit | 12,631 | 9,400 | 7,891 | 6,986 | 5,817 | Upgrade
|
| Selling, General & Admin | 1,777 | 1,437 | 1,371 | 1,154 | 1,026 | Upgrade
|
| Research & Development | - | 737.2 | 631.9 | 592.7 | 536.9 | Upgrade
|
| Other Operating Expenses | 3,420 | 1,683 | 1,456 | 1,275 | 952 | Upgrade
|
| Operating Expenses | 5,857 | 4,391 | 3,908 | 3,489 | 2,884 | Upgrade
|
| Operating Income | 6,774 | 5,009 | 3,984 | 3,496 | 2,933 | Upgrade
|
| Interest Expense | -6.1 | -7.8 | -7.8 | -7 | -15.9 | Upgrade
|
| Interest & Investment Income | - | 472.8 | 354.1 | 235 | 186.1 | Upgrade
|
| Earnings From Equity Investments | -0.1 | 2.7 | 0.8 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 113.1 | 138.2 | 109.8 | 7.2 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 60.7 | 48.2 | 23 | 31.5 | Upgrade
|
| EBT Excluding Unusual Items | 6,768 | 5,651 | 4,517 | 3,857 | 3,142 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -6.5 | -3.6 | 1.2 | -6 | Upgrade
|
| Pretax Income | 6,768 | 5,644 | 4,514 | 3,858 | 3,136 | Upgrade
|
| Income Tax Expense | 1,357 | 1,030 | 743.6 | 773.7 | 621.9 | Upgrade
|
| Earnings From Continuing Operations | 5,411 | 4,614 | 3,770 | 3,085 | 2,514 | Upgrade
|
| Minority Interest in Earnings | -47.8 | -43.3 | -7.3 | -86.1 | -91.6 | Upgrade
|
| Net Income | 5,363 | 4,571 | 3,763 | 2,998 | 2,423 | Upgrade
|
| Net Income to Common | 5,363 | 4,571 | 3,763 | 2,998 | 2,423 | Upgrade
|
| Net Income Growth | 17.33% | 21.48% | 25.49% | 23.76% | 12.68% | Upgrade
|
| Shares Outstanding (Basic) | 76 | 76 | 76 | 76 | 76 | Upgrade
|
| Shares Outstanding (Diluted) | 76 | 76 | 77 | 76 | 76 | Upgrade
|
| Shares Change (YoY) | 0.04% | -0.26% | 0.18% | 0.07% | 0.11% | Upgrade
|
| EPS (Basic) | 70.57 | 60.19 | 49.62 | 39.61 | 32.03 | Upgrade
|
| EPS (Diluted) | 70.25 | 59.90 | 49.18 | 39.26 | 31.71 | Upgrade
|
| EPS Growth | 17.28% | 21.80% | 25.27% | 23.81% | 12.45% | Upgrade
|
| Free Cash Flow | 2,409 | 1,726 | 779 | 2,456 | 1,953 | Upgrade
|
| Free Cash Flow Per Share | 31.55 | 22.61 | 10.18 | 32.15 | 25.59 | Upgrade
|
| Dividend Per Share | - | 5.000 | 4.500 | 4.000 | 3.000 | Upgrade
|
| Dividend Growth | - | 11.11% | 12.50% | 33.33% | 20.00% | Upgrade
|
| Gross Margin | 62.10% | 55.42% | 53.74% | 54.96% | 54.76% | Upgrade
|
| Operating Margin | 33.30% | 29.53% | 27.13% | 27.51% | 27.61% | Upgrade
|
| Profit Margin | 26.37% | 26.95% | 25.62% | 23.59% | 22.80% | Upgrade
|
| Free Cash Flow Margin | 11.84% | 10.17% | 5.30% | 19.32% | 18.38% | Upgrade
|
| EBITDA | 7,434 | 5,507 | 4,399 | 3,939 | 3,285 | Upgrade
|
| EBITDA Margin | 36.55% | 32.46% | 29.96% | 30.99% | 30.92% | Upgrade
|
| D&A For EBITDA | 659.6 | 497.2 | 415.8 | 442.3 | 351.5 | Upgrade
|
| EBIT | 6,774 | 5,009 | 3,984 | 3,496 | 2,933 | Upgrade
|
| EBIT Margin | 33.30% | 29.53% | 27.13% | 27.51% | 27.61% | Upgrade
|
| Effective Tax Rate | 20.05% | 18.25% | 16.48% | 20.05% | 19.83% | Upgrade
|
| Revenue as Reported | 20,339 | 17,610 | 15,227 | 13,082 | 10,848 | Upgrade
|
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.